Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
128.79
Dollar change
+0.99
Percentage change
0.77
%
IndexS&P 500 P/E30.68 EPS (ttm)4.20 Insider Own0.42% Shs Outstand292.12M Perf Week1.71%
Market Cap37.68B Forward P/E21.27 EPS next Y6.06 Insider Trans-0.36% Shs Float291.34M Perf Month25.21%
Income1.24B PEG3.98 EPS next Q1.22 Inst Own89.74% Short Float / Ratio1.97% / 2.70 Perf Quarter5.64%
Sales6.83B P/S5.51 EPS this Y0.57% Inst Trans-3.32% Short Interest5.73M Perf Half Y8.94%
Book/sh20.01 P/B6.44 EPS next Y10.68% ROA11.65% Target Price129.35 Perf Year-16.90%
Cash/sh5.43 P/C23.70 EPS next 5Y7.70% ROE22.24% 52W Range96.80 - 160.26 Perf YTD-13.94%
Dividend0.94 P/FCF25.56 EPS past 5Y33.93% ROI14.45% 52W High-19.64% Beta1.10
Dividend %0.73% Quick Ratio1.97 Sales past 5Y7.00% Gross Margin57.94% 52W Low33.05% ATR3.01
Employees18100 Current Ratio2.61 Sales Q/Q-8.71% Oper. Margin23.85% RSI (14)74.70 Volatility1.61% 2.25%
OptionableYes Debt/Eq0.47 EPS Q/Q31.18% Profit Margin18.15% Rel Volume0.81 Prev Close127.80
ShortableYes LT Debt/Eq0.47 EarningsNov 20 AMC Payout21.48% Avg Volume2.12M Price128.79
Recom2.16 SMA2011.47% SMA5015.32% SMA2004.29% Volume1,728,785 Change0.77%
Date Action Analyst Rating Change Price Target Change
Nov-17-23Downgrade UBS Buy → Neutral $163 → $125
Sep-28-23Initiated Bernstein Mkt Perform $123
Jul-31-23Downgrade Evercore ISI Outperform → In-line $126 → $124
May-24-23Reiterated Wells Fargo Overweight $170 → $160
May-24-23Reiterated TD Cowen Outperform $168 → $145
May-24-23Reiterated SVB Securities Outperform $170 → $145
May-24-23Reiterated Stifel Hold $153 → $135
May-24-23Reiterated Robert W. Baird Outperform $174 → $144
May-24-23Reiterated Evercore ISI Outperform $150 → $126
May-24-23Reiterated Credit Suisse Outperform $170 → $160
Nov-21-23 05:12PM
04:14PM
03:42PM
01:20PM
12:35PM
12:12PM Loading…
12:12PM
12:00PM
11:08AM
10:02AM
07:33AM
Nov-20-23 07:28PM
06:00PM
04:41PM
04:22PM
04:05PM
02:49PM Loading…
02:49PM
11:56AM
07:52AM
Nov-19-23 06:33PM
Nov-17-23 11:59AM
Nov-16-23 11:01AM
09:21AM
Nov-15-23 06:15PM
04:02PM
Nov-14-23 04:01PM
08:00AM
Nov-13-23 05:42PM
10:00AM
08:00AM
Nov-08-23 06:15PM
02:38AM Loading…
02:38AM
Nov-07-23 07:40PM
Nov-01-23 06:15PM
Oct-31-23 08:05AM
Oct-30-23 07:41PM
09:53AM
Oct-26-23 06:15PM
Oct-23-23 01:30PM
10:28AM
Oct-19-23 09:15AM
Oct-13-23 06:51AM
Oct-10-23 10:43AM
Oct-06-23 01:26AM
Oct-05-23 12:55PM
Sep-29-23 01:26PM
Sep-20-23 03:06PM
01:13PM
10:15AM
Sep-18-23 09:00PM
01:03PM
Sep-15-23 01:11PM
Sep-14-23 11:30AM
Sep-12-23 08:35AM
Sep-05-23 10:36AM
07:45AM
07:40AM
07:35AM
07:20AM
05:34AM
Sep-01-23 08:34AM
Aug-24-23 08:00AM
Aug-21-23 04:26PM
10:49AM
Aug-17-23 11:38AM
Aug-16-23 05:07PM
01:48PM
12:59PM
12:37PM
07:55AM
Aug-15-23 08:04PM
06:31PM
06:27PM
06:00PM
04:15PM
04:05PM
Aug-13-23 02:00PM
Aug-11-23 11:56AM
Aug-09-23 06:15PM
08:00AM
Aug-03-23 08:00AM
07:25AM
Aug-02-23 03:32PM
Jul-31-23 04:26PM
09:00AM
Jul-26-23 06:15PM
Jul-19-23 12:00PM
Jul-10-23 10:52AM
08:01AM
Jul-06-23 06:15PM
Jul-05-23 08:09AM
Jul-03-23 01:29PM
08:00AM
Jun-29-23 06:15PM
Jun-23-23 06:15PM
Jun-22-23 11:30AM
08:00AM
Jun-14-23 11:54AM
Jun-13-23 12:02PM
Jun-12-23 08:00AM
Jun-08-23 08:00AM
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gonsalves RodneyV.P., Corporate ControllerSep 28Buy111.09328824,222Sep 29 04:03 PM
Gonsalves RodneyV.P., Corporate ControllerAug 23Sale118.783,500415,71624,219Aug 25 12:53 PM
McMullen Michael R.CEO and PresidentJul 27Option Exercise42.1294439,761261,813Jul 31 03:03 PM
McMullen Michael R.CEO and PresidentJul 27Sale130.00944122,720260,869Jul 31 03:03 PM
Ancher-Jensen HenrikSr Vice PresidentDec 14Sale155.7829,5004,595,51070,793Dec 15 12:22 PM
Grau DominiqueSenior Vice PresidentDec 13Sale159.204,000636,80092,379Dec 15 12:20 PM
MCDONNELL PADRAIGSr. Vice PresidentDec 13Sale160.00672107,52015,529Dec 15 12:21 PM
KOH BOON HWEEDirectorDec 06Sale152.2113,0001,978,69257,752Dec 08 11:31 AM